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Diphtheria is a respiratory disease caused by the bacterium Corynebacterium diphtheriae.
Although the development of a toxin-based vaccine in the 1930s has allowed a high level of
control over the disease, cases have increased in recent years. Here, we describe the genomic
variation of 502 C. diphtheriae isolates across 16 countries and territories over 122 years. We
generate a core gene phylogeny and determine the presence of antimicrobial resistance
genes and variation within the tox gene of 291 tox+ isolates. Numerous, highly diverse
clusters of C. diphtheriae are observed across the phylogeny, each containing isolates from
multiple countries, regions and time of isolation. The number of antimicrobial resistance
genes, as well as the breadth of antibiotic resistance, is substantially greater in the last
decade than ever before. We identified and analysed 18 tox gene variants, with mutations
estimated to be of medium to high structural impact.
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D iphtheria, traditionally regarded as a toxin-driven diseaseof the respiratory system, usually begins with angina ortonsillitis symptoms, sore throat and mild fever. However,
the clinical picture can quickly escalate leading to death if the
disease is not treated1. A white-grey pseudomembrane over
the pharynx, larynx and tonsils is considered stereotypical to the
disease, as is a swollen bull neck, although these symptoms are
not displayed in all the infected cases2,3. Once a common cause of
infection, diphtheria has been vaccine preventable for decades
and is now rarely observed in high income countries2,4. In low
and middle income countries, however, diphtheria is still of
concern as it can cause sporadic infections or outbreaks in
unvaccinated and partially vaccinated communities3,5. Any drop
in the levels of diphtheria vaccine coverage could potentially lead
to an opportunistic return of this communicable disease, as
already being reported for other vaccine-preventable diseases like
measles and pertussis6–9. The number of diphtheria cases
reported globally has followed a gradually increasing trend in
recent years, with the cases in 2018 (16,651) being over double the
1996–2017 average (8105)10.
Diphtheria is primarily caused by toxigenic Corynebacterium
diphtheriae, that colonise the upper respiratory tract11. The route
of transmission between humans is likely through droplets con-
taminated with C. diphtheriae12. The diphtheria toxin is encoded
on a tox+ corynephage in C. diphtheriae. Related species
including C. ulcerans and C. pseudotuberculosis can also be
lysogenised by this phage type, and such strains are also asso-
ciated with a clinical disease almost identical to diphtheria13–16.
In addition, non-toxigenic C. diphtheriae can cause disease, often
in the form of systemic infections17,18. Non-toxigenic but toxin
gene-bearing (NTTB) C. diphtheriae have also been recorded19,20.
Since the universal diphtheria vaccine is a partially pure toxoid
formulation, it may not be as effective for preventing NTTB led
infections. Acute diphtheria is usually treated with anti-
diphtheria toxin serum, alongside a course of antibiotics21.
While C. diphtheriae resistant to antibiotics have been reported,
the extent of such resistance in this pathogen remains largely
unknown2,22–24. A complete reference genome for C. diphtheriae
has been available for almost two decades25. Subsequent genomic
analysis has predominantly focused on small, geographically
clustered isolates, alongside reference genomes to provide a
context26–29.
In this work we seek to understand the genomic dynamics of C.
diphtheriae more widely with a detailed focus on India, where
over 50% of globally reported cases occurred in 201810. We
interrogate the genomes of a large collection of C. diphtheriae
isolates to determine their phylogenetic structure, assess the
presence of antimicrobial resistance (AMR) genes and assess
toxin variation, which is the key target of the current diphtheria
vaccine.
Results
Genomic insight into 122 years (1896–2018) of C. diphtheria.
A collection of 502 C. diphtheriae genomes was established by
sequencing 61 novel Indian isolates and combining these with
441 publicly available genomes. The isolates in our study cover 16
countries and territories and they were collected across a period
of 122 years. As India has reported the highest number of cases in
the last few years, a separate Indian subset totalling 122 genomes
with two isolates from 1973 and the rest collected between 2015
and 2018 (including the 61 novel isolates), was created and
analysed.
An initial analysis of the total 502 C. diphtheriae genomes
showed that, as previously reported, it is a genetically diverse
species. An initial mapping analysis revealed evidence for
extensive recombination across the whole species, not conducive
to an accurate phylogeny (Supplementary Fig. 1). 100 Multilocus
sequence types (MLST) were determined, with 73 isolates
designated as ‘novel STs’. The core gene list was calculated to
be 1035 genes with an extended pan gene list accumulating to
23,447 genes. The Indian subset had 1367 core genes but a lower
number of 7436 genes in the pan gene list across all 122 genomes
(Supplementary Fig. 2).
Figure 1A displays the outcome of the phylogenetic analysis of
all 502 genomes included in our study. Built from a 49,454
nucleotide long core gene single nucleotide polymorphism (SNP)
alignment, the phylogenetic tree in Fig. 1A indicated the presence
of several clusters across the collection, each containing isolates
from wide temporal and spatial ranges. Within these clusters,
single monophyletic groups were readily identifiable, and these
predominantly showed strong geographic and temporal associa-
tion. Isolates within a particular monophyletic group shared a
single ST, although some individual isolates within these groups
were also ‘novel STs’. One subclade spread extensively to cover
multiple neighbouring European countries—predominantly
Belarus and Germany—and persisted over a large period of time
(marked by a blue star). Isolates within this lineage were isolated
as early as 1996 and persisted until at least 2017 when isolates
were found in Germany. Clusters contained groups isolated from
multiple continents, most commonly Asia and Europe. This
clearly indicates that C. diphtheriae has been established in the
human population for at least over a century and has spread,
potentially by population movements, across time and space. This
also shows that there are multiple distinct clonal populations
circulating in the same geographical setting1,29.
Within India, isolates from individual monophyletic groups
were from multiple states, spanning both Northern and Southern
India (Fig. 1B). The closely related monophyletic groups of
similar origins suggest clonal outbreaks occurring opportunisti-
cally, perhaps emerging from commensalism when favourable
factors occurred.
tox gene diversity. Diphtheria toxin is the main virulence-
associated factor in the disease. In total, 18 allelic variants of the
tox gene were found across the 291 tox+ isolates, which make
58% of the total collection of 502. Of these 18 allelic types, eight
were found to contain non-synonymous SNP changes with types
5, 8, 14, 15, 17 and 18 each containing one amino acid sub-
stitution. Toxin type 7 contained two amino acid substitutions,
one of which was shared with type 8. Group 13 instead harboured
a deletion, previously reported to result in the strain being NTTB.
The impact of these non-synonymous mutations on the protein
structure was estimated using PHYRE2 and SuSPect, and were
plotted onto the diphtheria toxin protein model 1XDT (https://
www.rcsb.org/structure/1xdt) from the Protein Data bank using
UCSF ChimeraX (Fig. 2)30–34. Groups 13 deletion and group 14
mutations were both present in the signal sequence of the gene,
and thus could not be mapped to the protein structure. Groups 7
and 8 shared mutation was estimated to have low impact, the
second mutation in group 7 as well as groups 5, 15, 18 were
calculated as moderate impact mutation, while group 17 mutation
was calculated as a high impact mutation. Notably, the site of
groups 15, 17 and 18 mutations had a much higher average
mutation impact, with many of the potential amino acid sub-
stitutions showing a high risk of mutations impacting on the
toxin structure. The proportions of the tox allelic variants found
in each decade is shown in Fig. 1C. The most common toxin
variant was type 16 (49.5% of toxigenic isolates), with 4, 6, 8, 11
and 15 being the next most common alleles. Type 16 also includes
the tox variant found in the vaccine strain, PW835. Three C.
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diphtheriae isolates carried two identical copies of the tox gene,
two type 7 isolated in Germany and Switzerland, and one type 16
isolated in Germany. tox variant diversity significantly increases
by decade (r (9)= 0.70, p= 0.02), although this may be because
of unavoidable bias of sampling. Supplementary Figs. 3, 4 show
the breakdown of tox types by country of origin and year of
isolation. Non-toxigenic isolates were much more common in
mainland Europe, Brazil and Australia than in India and
Fig. 2 Six non-synonymous mutations plotted onto diphtheria toxin model 1XDT (https://www.rcsb.org/structure/1xdt) from the Protein Data Bank
using PHYRE2. The impact of these mutations is estimated by SuSPect, with a gradient per mutation of low (dark blue) to high (orange/red).
Fig. 1 Global and Indian core gene phylogenies of Corynebacterium diphtheriae and tox gene variants by decade. A Maximum likelihood phylogenetic
tree based on the core gene single nucleotide polymorphisms from the 502 global Corynebacterium diphtheriae genome collection. The country of
isolation (1), decade of isolation (2), and AMR gene presence/absence heatmap made using ARIBA50 (3), are all annotated. Most monophyletic groups
within the tree represent only one country and decade, with the major exception of the large Belarussian/German dominated group, marked with a blue
star. Both the blue and orange stars highlight groups used for BEAST analysis. B The core gene maximum likelihood phylogeny of only the 122 Indian
isolates, coloured by state (1) and year of isolation (2). C The proportion of the 18 tox gene variants found across 291 tox+ and 211 non-toxigenic isolates
per decade, with the number of isolates per decade shown.
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Southeast Asia, as well as being more common in more recently
isolated genomes (non-toxigenic isolates per decade (r (9)= 0.60,
p= 0.05). The difference between the number of non-toxigenic
and toxigenic isolates in HICs and LMICs was significantly dif-
ferent (r (1)= 202.67, p < 0.001). Group 16 was the predominant
variant across South Asia, while being much less common outside
the region. Group 16 was also the predominant variant in recent
years, despite the rise in non-toxigenic isolates. Some tox variants
were present only within a single monophyletic group and loca-
tion e.g. type 8, only present in 18 South African isolates, and
groups 17 and 18, only present in one isolate each from Australia.
Others including types 4 and 16 were present throughout the
phylogeny, across numerous clusters and groups.
Figure 3 shows the proportion of each tox type per state across
India. Four of the eighteen toxin types were represented among
the Indian isolates, with Group 16 still being the dominant
variant. Types 2 and 11 were only present in Kerala. The only
non-toxigenic Indian isolates were found in the South, in Tamil
Nadu and Kerala.
Antimicrobial resistance in C. diphtheria. The AMR gene
portfolio (Fig. 1A) and the average number of AMR genes per
decade (Supplementary Fig. 5) were evaluated. More recently
isolated genomes (including those from India) showed a dis-
proportionately high number of AMR genes, with a significant
positive correlation between the average number of AMR genes
per genome and the decade of isolation (r (9)= 0.68, p= 0.02).
Similar resistance profiles were found across a small number of
recent Swiss and German isolates. The sulphonamide resistance
gene (sulI) was the most common, being consistently found in
Indian and sporadically in other Asian and European isolates.
Aminoglycoside (aadA4, aph3_Ia, strA and strB), chlor-
amphenicol (cmr) and trimethoprim (dfrA1) resistance genes
were also present in most recent Indian isolates. Only one isolate
(from India) was found to contain a macrolide resistance-
encoding gene (msrA), while no isolates harboured β-lactam
resistance genes. Isolates from the decade of 2010 to 2019 shows
the highest average number of AMR genes per genome, almost
four times as many genes on average than in the next highest
decade; the 1990s (Supplementary Fig. 5). The 2010s also showed
more variation in the classes resisted (six), compared to other
decades.
Within the Indian isolates, C. diphtheriae from Himachal
Pradesh (isolated in 1973) had no detectable AMR genes (Fig. 3).
Isolates from Haryana harboured genes encoding resistance to
four classes of antibiotic, whereas isolates from Delhi, Kerala and
Tamil Nadu had genes for resistance to five. Isolates from the
most populous state of India, Uttar Pradesh, showed resistance to
six classes, including the only isolate of our study with macrolide
resistance. Five isolates from Kerala (all isolated in 2016) and one
from Uttar Pradesh (isolated in 2017) showed no AMR genes
present in their genomes. Phenotypic AMR testing was carried
out for the 61 novel Indian isolates and these results align well
with the genes found in silico (Supplementary Data 1).
Time scaled phylogenetic analysis. The European and Indian
groups (marked with blue and orange stars respectively on
Fig. 1A) are shown in Supplementary Figs. 6, 7. BEAST estimates
Fig. 3 The antimicrobial resistance (AMR) gene and tox gene variant proportions represented in the 122 Corynebacterium diphtheriae genomes from
India at state level. The number of isolates from the six states sampled are shown in circles on the map. The AMR genes are coloured by the classes of
antibiotic the genes offer resistance to. AGly (blue) aminoglycosides, MLS (purple) macrolide–lincosamide–streptogramin, Phe (yellow) phenicols, Sul
(green) sulfonamides, Tet (orange) tetracyclines, Tmt (light blue) trimethoprim. The map was taken from Google Maps47.
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the European group’s most recent shared ancestor was in
September 1983. Three clades are present within the main Eur-
opean clade with the first spanning March 1987–2008. The sec-
ond and third clades are estimated to have diverged in July 1985
with the former present from September 1988 to 2010 and the
latter estimated to being in circulation between April 1990 and
2017. The ratio of pre- and post-recombination removal SNPs
included in the alignment was 1.1 (1944:1783).
The Indian group is estimated to have shared an ancestor with
the reference isolate NCTC11397 in October 1955, before
diverging into two clades in February 2009. The first clade is
estimated to have run from April 2012 to 2017, with the second
from June 2013 to 2018. The ratio of pre- and post-
recombination removal SNPs included in the alignment was 1.2
(26879:22717).
Corynephage variation. The maximum likelihood phylogeny of
11 toxigenic corynephages from complete C. diphtheriae genomes
can be seen in Supplementary Fig. 8, based on a mapped align-
ment of 36,570 nucleotide bases. There were no major phyloge-
netic correlations with the country of isolation and the decade of
isolation as closely related corynephages being isolated over large
temporal and geographical distances. The tox gene variant carried
by the corynephage also does not correspond with the phyloge-
netic structure, with groups 6 and 16 found in distantly related
isolates across the phylogeny.
Discussion
By analysing a large collection of C. diphtheriae genomes we
identified numerous clades distributed across the globe. Indivi-
dual clades contained monophyletic groups isolated from multi-
ple countries and regions across our sampling time frame. In
India, where the majority of recently reported diphtheria cases
originate, numerous monophyletic groups were found across the
phylogeny as several independent lineages. These sub-lineages of
C. diphtheriae thus represent a persisting and apparently suc-
cessful diverse population. This is in contrast to other bacterial
pathogens such as Mycobacterium abscessus, which are repre-
sented by largely clonal lineages that have spread across the globe.
The high level of diversity and recombination once again
highlights the major challenges of creating high confidence
phylogenies of C. diphtheriae. Core gene approaches remain the
most robust methodologies for building phylogenies of large
C. diphtheriae collections to cope with the large diversity and
recombination across major clades. Mapping approaches and
recombination removal have been demonstrated as possible for
closely related groups, highlighting the need for more high-
quality reference genomes representing these currently circulating
lineages. We were able to use BEAST to create time-scaled phy-
logenies of individual closely related monophyletic groups, reaf-
firming the importance of these high-quality reference genomes.
This demonstrates that time-scaled phylogenies could be used to
accurately analyse individual outbreaks and support public health
measures, provided a single group of C. diphtheriae is responsible,
rather than numerous clusters concurrently as seems to be the
case in India and other parts of the world.
Although our study is based on a comprehensive clinical strain
collection, our study lacks data on carriage isolates from non-
clinical cases, as C. diphtheriae is not routinely screened for in
healthy individuals. Nevertheless, the spatio-temporal structure of
the phylogeny suggests that carriage could be playing a significant
role in the overall persistence and evolution of the C. diphtheriae
species. Therefore, in future studies, it is important to monitor the
human population for asymptomatic carriage in both vaccinated
and unvaccinated individuals, especially in at-risk communities
and known epidemiological hot spots.
While our data does not, at present, highlight any efficacy
concern in the currently used tox variant type 16 based diphtheria
toxoid vaccine, the continually increasing toxin diversity and
prevalence of non-toxigenic strains do however forecast a real
possibility of vaccine escape and anti-toxin treatment failure in
future. While the current vaccine against diphtheria continues to
remain largely effective, it is vital to conduct further in vitro and
in vivo studies to investigate the benefit, if any, that the six var-
iants with non-synonymous allelic mutations that impact protein
structure may provide to C. diphtheriae, especially those esti-
mated to have moderate and high impacts on structure. Further
sequencing of C. diphtheriae isolates may reveal additional var-
iant types and show the full extent of the spread of the variants
catalogued by us. This evolutionary tracking is of critical
importance as it will forewarn the public health agencies of any
possible vaccine escape or anti-toxin treatment failure, allowing
the planning of early alternate intervention. Our analysis of the
corynephage genome, while preliminary, suggests the diversity in
the tox gene is not merely a product of wider phage diversity. Due
to being based on only the limited number of complete genomes
that carried the corynephage, this conclusion requires further
investigation as the number of public completed C. diphtheriae
genomes increases. With a steady global increase in vaccination
rates for diphtheria, the selection pressure on the toxin as the
main antigen is bound to increase, and this may be the reason
behind the increase in non-toxigenic isolates recorded, as well as
the significantly lower proportion of the 18 tox variants found
among higher income countries. Among the isolates from Eur-
ope, where variant 16 now makes up only a small fraction of tox
variants found, and where non-toxigenic isolates have been more
commonly reported, further research utilising this toxin diversity
information is imperative, as is more detailed investigations into
the mechanisms of non-toxigenic infection. Using advanced
phylogenomics, our data guides public health preparedness and
suggests that a plan B in hybrid toxin-based vaccine candidates
and antitoxins must be pre-emptively prepared for action if a
non-synonymous non-group 16 toxin carrying C. diphtheriae
were to abruptly become prevalent.
AMR has rarely been considered as a major problem in the
treatment of C. diphtheriae. Here, we demonstrate that recently in
some parts of the world, genomes are acquiring resistance to
numerous classes of antibiotics, likely driven through the overall
exposure to antimicrobials and the common co-occurrence of
different resistance elements on the same mobile elements. The
resistance genotypes are not limited to a single country or region
but present in both Asia and Europe. Despite erythromycin and
penicillin being the traditionally recommended antibiotics of
choice for treating confirmed cases of early-stage diphtheria, only
one macrolide resistance gene was found, and no resistance to
β-lactamases. This indicates that AMR acquisition in C. diph-
theriae could be happening during its purported carriage state
and in response to the exposure to antibiotics in their environ-
ment or during patient treatment against other infections. The
independent acquisition of highly similar AMR genes in C.
diphtheriae indicates recombination between these lineages and
acquisition of mobile elements from other species. It could also be
due to collateral selection, where pressure to acquire resistance to
one antimicrobial agent may drive the advancement of resistance
to other agents by its very development36.
Although the results from our study are based on a compre-
hensive clinical strain collection of isolates and genomes,
our study lacks data on carriage isolates, which could be playing
a highly significant role in the overall evolution of the
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C. diphtheriae species. Our phylogenomic findings strengthen the
hypothesis that while the diphtheria vaccine may be effective in
preventing the symptomatic infection, carriage in vaccinated
individuals or asymptomatically infected individuals could be
continuing to provide a suitable ecosystem for C. diphtheriae
sustenance for prolonged periods. COVID-19 has negatively
impacted childhood vaccination schedules worldwide, with
diphtheria doses scheduled at 6, 10 and 14 weeks. This coupled
with reported case numbers rising over the past decade, and the
year 2018 showing the highest incidence in 22 years, it is more
important than ever to understand this historically important
disease, to prevent it from becoming a major global threat ever
again in its original or a modified, better adapted, form.
Methods
Data collection. Sixty-one novel isolates were identified from 3 Northern Indian
states. Of these, 22 isolates were from patients in Delhi, 7 from Haryana, and 32
from Uttar Pradesh. Nine were isolated in 2015, 16 in 2016, 34 in 2017, and 2 in
2018. Genomes of all these isolates have been made publicly available, with
accession numbers found in Supplementary Data 1. Novel Indian isolates were
grown, and DNA extracted for sequencing. Whole Genome Sequencing was carried
out using an Illumina HiSeq v4 platform at Wellcome Sanger Institute, producing
short read whole genome sequences that were assembled and annotated using
SPAdes assembly (v3.13.0) and Prokka annotation (v1.5)37,38. Publicly available
genomic data and metadata were collated following a literature review, to frame a
global representation. We also analysed our novel isolates within an Indian context,
to allow comparison between the global picture and the country with the highest
reported case numbers to the World Health Organisation. Microreact (v5.93.0)
plots have been produced for both the global (https://microreact.org/project/
CZaifLUuW) and the Indian collections (https://microreact.org/project/TuIdKrIfc)
to aid in data sharing39.
Core gene phylogeny. Due to the extremely high recombinogenic variation
between the genomes of C. diphtheriae identified using Gubbins (v2.4.1) and
Phandango (v0.9)40,41, which is not conducive to an accurate phylogeny, we chose
Roary (v3.13.0)42 instead to investigate the phylogenetic relationships between
isolates. Using annotated genomes produced by Prokka (v1.5)38, Roary extracted
the genes present in 99% of the isolates, concatenating them to produce a core gene
alignment. The number of genes across the pan-genome categories was deter-
mined. SNPs were identified using SNP-sites (v2.5.1)43 and used to produce a core
gene maximum likelihood phylogenetic tree, using IQ-TREE (v1.6.10) and the
inbuilt ModelFinder over 1000 pseudo-bootstrap replicates44,45.
Genomic analysis. Results, alongside the spatial and temporal metadata, were
annotated to the phylogenetic trees using the Interactive Tree of Life (iTOL)
(v5.5.1)46, to determine any epidemiological relatedness between the different
phylogenetic and phylogeographic clades. To display the toxin variants and AMR
genes per Indian state, a map was taken from Google Maps47. The MLST of all
isolates was determined using MLSTcheck (v2.1.1706216)48.
tox Gene analysis. Variation in the tox gene was investigated by obtaining the
gene sequence from 291 toxigenic isolates using in silico PCR49. Primers are
available in Supplementary Table 1. The non-synonymous mutations found were
plotted onto diphtheria toxin model 1XDT from the Protein Data Bank using
UCSF ChimeraX (v1.1), and the risk of those mutations impacting on protein
structure was calculated using PHYRE2 (v2.0) and the inbuilt SuSPect30–34.
Antimicrobial resistance testing. ARIBA (v2.14.6) was used to interrogate the
genome for the presence of antimicrobial resistance (AMR) genes, to investigate if
resistance was now becoming a concern in C. diphtheriae globally50. Antimicrobial
susceptibility test was performed using MICs gradient test (E-test, BioMèrieux,
Marcy, l’Etoile, France). The E-test strips of ampicillin (AM), amoxicillin/clavu-
lanic acid (XL), azithromycin (AZ), ciprofloxacin (CI), chloramphenicol (CL),
clindamycin (CM), cefotaxime (CT), doxycycline (DC), erythromycin (EM), gen-
tamycin (GM), imipenem (IP), linezolid (LZ), moxyfloxacin (MX), penicillin (PG),
rifampicin (RI), tetracycline (TC, ceftriaxone (TX), vancomycin (VA),
trimethoprime–sulphamethoxazole (SXT) on Mueller-Hinton agar plates with 5%
horse blood. Corynebacterium spp. MIC interpretative standard was based on the
Clinical and Laboratory Standards Institute51.
Statistics. RStudio (v4.6.1) was used to carry out Pearson’s product-moment
correlation to determine the significance between decade of isolation and tox
gene variety, the average number of AMR genes per genome, and the number
of non-toxigenic isolates per decade, while a chi-squared test of non-toxigenic and
toxigenic isolates from HICs and LMICs52,53.
Time scaled phylogenetic analysis. Two closely related clades were chosen for
time-scaled phylogenetic analysis. Recombination was removed from the mapped
alignments using Gubbins (v2.4.1) before using the BEAST (v1.10) package to carry
out the Bayesian time-scaled phylogenetic analysis40,54. The Hasegawa, Kishino
and Yano model (HKY) substitution model with different demographic models
(Bayesian skyline, exponential and constant) was investigated. Markov chain
Monte Carlo runs of 100 million generations were carried out with sampling of
20,000 generations55. The convergence of each run was manually inspected using
Tracer (v1.7)56. A burn in of 20% was discarded from the runs and maximum clade
credibility tree was finally generated using Treeannotator (v1.8.2)57. The annotated
phylogenetic tree was visualised using FigTree (v1.4)58.
Corynephage analysis. Corynephage diversity was investigated by mapping the 11
toxigenic complete genomes publicly available from NCBI Genbank to the cor-
ynephage sequence annotated in C. diphtheriae isolate NCTC 13129 using BWA
(v0.7.17-r1188)59,60. This mapped alignment was then used to produce a maximum
likelihood phylogenetic tree with IQ-TREE (v1.6.10) and the inbuilt ModelFinder
over 1000 pseudo-bootstrap replicates, and annotated using iTOL (v5.5.1)44–46.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The novel genome sequences generated during and analysed during the current study are
available in the NCBI Genbank repository, under the study ID PRJEB20897. Source data
are provided with this paper.
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